2003
DOI: 10.1046/j.1528-1157.2003.58102.x-i1
|View full text |Cite
|
Sign up to set email alerts
|

Nicotine as an Antiepileptic Agent in ADNFLE: An N‐of‐One Study

Abstract: Summary:Purpose: To test nicotine patch treatment for a patient with a defined mutation for autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) whose seizures were refractory to standard antiepileptic therapy.Methods: Open and double-blind trials of nicotine patches in an "n-of-one" study. The double-blind trial comprised periods during which either placebo or nicotine patches were each used for three periods of 2 weeks, randomized in a double-blind manner.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0
2

Year Published

2005
2005
2021
2021

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(26 citation statements)
references
References 6 publications
1
23
0
2
Order By: Relevance
“…Nicotine seizures in L9ЈA mice consist of forelimb clonus and loss of righting response (which can also be described as asymmetrical posturing). (2) Nicotine suppressed ADNFLE seizures in the single patient tested to date (Willoughby et al, 2003). Nicotine pretreatment blocked nicotine-induced seizures in L9ЈA mice.…”
Section: Similarities With Adnflementioning
confidence: 93%
See 2 more Smart Citations
“…Nicotine seizures in L9ЈA mice consist of forelimb clonus and loss of righting response (which can also be described as asymmetrical posturing). (2) Nicotine suppressed ADNFLE seizures in the single patient tested to date (Willoughby et al, 2003). Nicotine pretreatment blocked nicotine-induced seizures in L9ЈA mice.…”
Section: Similarities With Adnflementioning
confidence: 93%
“…6 B, D). The following compounds were tested for their ability to prevent nicotine-induced seizures in L9ЈA and WT mice: (1) carbamazepine, a commonly used antiepileptic; (2) dihydro-␤-erythroidine (DH␤E), a competitive nicotinic antagonist with high affinity for ␣4/␤2 receptors; (3) hexamethonium, a nicotinic antagonist with poor brain-barrier permeability and thus suspected of preferentially targeting nicotinic receptors in the periphery; (4) mecamylamine, a potent wide-spectrum nicotinic antagonist, and (5) nicotine, reported to prevent seizures in an otherwise drug-resistant AD-NFLE patient (Willoughby et al, 2003). All pretreatment drugs were dissolved in saline, except for carbamazepine, which was suspended in 1% Tween 80.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mutations of gene coding for neuronal nicotinic acetylcholine receptors can result in a form of autosomal dominant nocturnal frontal lobe epilepsy. Willoughby et al (75) used a nicotine patch treatment for a patient with a defined mutation for autosomal dominant nocturnal frontal lobe epilepsy whose seizures were refractory to standard antiepileptic therapy. In this N-of-one study, the patient responded remarkably well to the patch.…”
Section: Treatment Of Nocturnal Seizures: Are We Still In the Dark? Bmentioning
confidence: 99%
“…The wide variations in incidence of epilepsy are explained by differences in diagnostic criteria and selection of patients. Those with short febrile seizures were mainly in prospective studies and rarely developed spontaneous seizures, whereas patients with complicated febrile seizures had often presented at a later age with epilepsy, and 17% had records of brain injury at birth [2]. In a prospective study of 110 unselected FS patients followed for ~2 years by the author, spontaneous nonfebrile seizures occurred in 17%, they were recurrent in 12%, and were frequent in 4% [3].…”
mentioning
confidence: 99%